ARTICLE | Clinical News
Epodure: Interim Phase IIa data
May 6, 2013 7:00 AM UTC
Interim data from 4 ESRD patients with anemia who are on dialysis in an open-label, Israeli Phase IIa trial showed that a single treatment of 19-51 IU/kg/day subcutaneous Epodure maintained hemoglobin...